Varenicline for Co-occurring Cannabis and Tobacco Use

PHASE4CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Cannabis DependenceTobacco Dependence
Interventions
DRUG

Standard clinical care first, followed by standard clinical care and varenicline

Standard clinical care includes substance use disorder treatment program-based individual behavioral counseling at least once a month using motivational and cognitive behavioral strategies. Varenicline therapy includes a one month's supply of the medication in standard doses: 0.5 mg for 3 days, 0.5 mg twice a day for 4 days, then 1 mg twice a day for 21 days.

DRUG

Standard clinical care and varenicline first, followed by standard clinical care

Standard clinical care includes substance use disorder treatment program-based individual behavioral counseling at least once a month using motivational and cognitive behavioral strategies. Varenicline therapy includes a one month's supply of the medication in standard doses: 0.5 mg for 3 days, 0.5 mg twice a day for 4 days, then 1 mg twice a day for 21 days.

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

Albert Einstein College of Medicine

OTHER

NCT04595318 - Varenicline for Co-occurring Cannabis and Tobacco Use | Biotech Hunter | Biotech Hunter